Get the Stockscreener App
26.21
1.47%
0.38
After Hours:
26.18
-0.03
-0.11%
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc stock is traded at $26.21, with a volume of 20.89M.
It is up +1.47% in the last 24 hours and down -7.91% over the past month.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
See More
Previous Close:
$25.83
Open:
$25.83
24h Volume:
20.89M
Relative Volume:
0.59
Market Cap:
$148.53B
Revenue:
$59.37B
Net Income/Loss:
$4.25B
P/E Ratio:
14.32
EPS:
1.83
Net Cash Flow:
$8.23B
1W Performance:
+2.18%
1M Performance:
-7.91%
6M Performance:
-5.79%
1Y Performance:
-12.87%
1-Day Range:
$25.77
$26.23
1-Week Range:
$25.61
$26.45
52-Week Range:
$24.48
$31.54
Pfizer Inc Stock (PFE) Company Profile
Name
Pfizer Inc
Sector
Industry
Phone
(212) 733-2323
Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
26.21 | 148.53B | 59.37B | 4.25B | 8.23B | 0.74 |
|
LLY
Lilly Eli Co
|
795.35 | 755.90B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
106.80 | 474.49B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
155.01 | 353.35B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
182.93 | 323.26B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
101.64 | 257.11B | 63.17B | 12.15B | 14.84B | 4.77 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-25-24 | Resumed | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Aug-07-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Mar-22-24 | Downgrade | Argus | Buy → Hold |
| Feb-23-24 | Initiated | Guggenheim | Buy |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Oct-20-23 | Resumed | UBS | Neutral |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Neutral |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Jun-29-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-11-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Mar-06-23 | Initiated | Jefferies | Hold |
| Feb-07-23 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-26-23 | Downgrade | UBS | Buy → Neutral |
| Jan-17-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-04-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-03-22 | Reiterated | Bernstein | Mkt Perform |
| Dec-20-21 | Reiterated | Cowen | Outperform |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Upgrade | UBS | Neutral → Buy |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Jul-27-21 | Resumed | Truist | Buy |
| May-06-21 | Downgrade | Mizuho | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Feb-04-21 | Upgrade | DZ Bank | Hold → Buy |
| Dec-16-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-19-20 | Resumed | Goldman | Neutral |
| Nov-10-20 | Resumed | Bernstein | Mkt Perform |
| Oct-12-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-16-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-27-20 | Upgrade | Standpoint Research | Hold → Buy |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Outperform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Jul-30-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-30-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-19 | Resumed | Morgan Stanley | Overweight |
| Feb-20-19 | Resumed | Citigroup | Neutral |
| Jan-31-19 | Upgrade | Argus | Hold → Buy |
| Jan-31-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-23-19 | Downgrade | UBS | Buy → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-01-18 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
View All
Pfizer Inc Stock (PFE) Latest News
Edgestream Partners L.P. Boosts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Caisse DE Depot ET Placement DU Quebec - MarketBeat
Captrust Financial Advisors Decreases Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Rockefeller Capital Management L.P. Buys 32,524 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Quantbot Technologies LP Acquires New Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Fmr LLC Buys 435,311 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Short Interest Up 52.8% in November - MarketBeat
Prurigo Nodularis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Celgene Crp., Novartis, Pfizer, Galderma, Genentech, Incyte Crp., Trevi Therapeutics, Vyne Therap - The Globe and Mail
Pfizer (NYSE:PFE) Trading 1.2% HigherTime to Buy? - MarketBeat
Is This a New Reason to Buy Pfizer Stock Hand Over Fist? - sharewise
How Much Would It Take To Earn $100 A Month From Pfizer Stock? - Yahoo Finance
PFIZER INC : Berenberg remains Neutral - Marketscreener.com
Analyst recommendations: Apple, Dell, Pfizer, Wall Disney, GSK... - Marketscreener.com
Sleep Aids Market Overall Study Report 2024-2031 | Pfizer Inc., - openPR
Black Friday Sale for Income Investors: These 3 Ultra-High-Yield Dividend Stocks Are Bargain Buys - The Motley Fool
Pfizer (NYSE:PFE) Shares Up 0.2%Here's Why - MarketBeat
Pfizer (PFE) Down 9.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is Pfizer Stock in Trouble? - sharewise
Vinva Investment Management Ltd Buys 146,564 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Are Investors Undervaluing Pfizer (PFE) Right Now? - Yahoo Finance
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Has $70.24 Million Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
CreativeOne Wealth LLC Has $3.41 Million Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Glenmede Trust Co. NA Cuts Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Why Pfizer Inc. (PFE) Is One of the Most Undervalued Pot Stocks to Buy? - MSN
Pfizer (NYSE:PFE) Trading Up 0.3%Should You Buy? - MarketBeat
Pfizer wins lawsuit - JD Supra
Pfizer Inc. (NYSE:PFE) Shares Sold by MetLife Investment Management LLC - MarketBeat
Which is a Better Buy: Moderna or Pfizer? - Baystreet.ca
Healthcare of Ontario Pension Plan Trust Fund Boosts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Clifford Capital Partners LLC Purchases 51,703 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Townsquare Capital LLC Has $21.49 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Bought by Cadence Bank - MarketBeat
Pfizer Inc. (NYSE:PFE) Stock Holdings Cut by The Manufacturers Life Insurance Company - MarketBeat
Dai ichi Life Insurance Company Ltd Has $7.06 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
High-Quality Dividend Growth Stocks Near 52-Week Lows: Pfizer Is Fun - Seeking Alpha
Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead? - Yahoo Finance
John Dorfman: Pfizer, Schlumberger are January Bounce candidates - TribLIVE
Pfizer (NYSE:PFE) Trading Down 1.7%Here's What Happened - MarketBeat
Hypopituitarism Treatment Market to Witness Huge Growth - openPR
PFIZER INC. (PFE) - MSN
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - MSN
D.A. Davidson & CO. Buys 233,609 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Fisher Asset Management LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Anti infective Agents Market to See Huge Growth by 2024 | Pfizer, Merck, GSK - openPR
Unit Dose Packaging Market Top PlayersPfizer Inc., Amcor Plc, - openPR
Zai Lab, Pfizer team up to widen China access to antibacterial Xacduro - BioWorld Online
Pfizer (NYSE:PFE) Stock Price Up 1.8%Here's Why - MarketBeat
Bridgebio, with FDA approval, faces Pfizer in ATTR - BioWorld Online
Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch
Pfizer Inc Stock (PFE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.00%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):